4//SEC Filing
LaBrosse Nicole 4
Accession 0001415889-25-005173
CIK 0001159036other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:49 PM ET
Size
7.9 KB
Accession
0001415889-25-005173
Insider Transaction Report
Form 4
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
Transactions
- Award
Option to Purchase Common Stock
2025-02-20+22,603→ 22,603 totalExercise: $57.44From: 2026-02-20Exp: 2035-02-20→ Common Stock (22,603 underlying) - Award
Restricted Stock Units
2025-02-20+21,327→ 21,327 totalExercise: $0.00From: 2026-02-20→ Common Stock (21,327 underlying)
Footnotes (2)
- [F1]This option vests one-fourth on such date and then 1/48th monthly thereafter.
- [F2]This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001910662
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:49 PM ET
- Size
- 7.9 KB